We report a patient with a history of leukopenia who developed acute myeloid leukemia (AML) FAB M2 and was successfully treated with induction and consolidation chemotherapy. She relapsed 7 months after initial diagnosis. Peripheral blood cells at relapse showed a t(12;15)(p13;q13), which has not been previously described in de novo or relapsed AML.
|Original language||English (US)|
|Number of pages||3|
|Journal||Cancer Genetics and Cytogenetics|
|State||Published - Feb 1996|
ASJC Scopus subject areas
- Molecular Biology
- Cancer Research